Literature DB >> 25680441

Elevated fecal calprotectin in patients with Alzheimer's dementia indicates leaky gut.

Friedrich Leblhuber1, Simon Geisler, Kostja Steiner, Dietmar Fuchs, Burkhard Schütz.   

Abstract

Fecal concentrations of calprotectin were examined in 22 patients with Alzheimer's disease (AD) and compared with serum concentrations of aromatic amino acids. Calprotectin concentrations were mean ± SEM 140 ± 31.9 mg/kg, 16 patients (73%) presented with concentrations outside normal (>50 mg/kg). Concentrations correlated inversely with serum levels of tryptophan, tyrosine and phenylalanine (all p < 0.05). Increased concentrations of fecal calprotectin indicate a disturbed intestinal barrier function in AD patients which could be of relevance for the lowering of essential aromatic amino acids concentrations in the blood.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25680441     DOI: 10.1007/s00702-015-1381-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  16 in total

Review 1.  The role of S100a9 in the pathogenesis of Alzheimer's disease: the therapeutic effects of S100a9 knockdown or knockout.

Authors:  Keun-A Chang; Hee Jin Kim; Yoo-Hun Suh
Journal:  Neurodegener Dis       Date:  2012-02-01       Impact factor: 2.977

2.  Respiratory infection promotes T cell infiltration and amyloid-β deposition in APP/PS1 mice.

Authors:  Róisín M McManus; Sarah C Higgins; Kingston H G Mills; Marina A Lynch
Journal:  Neurobiol Aging       Date:  2013-08-29       Impact factor: 4.673

3.  Simultaneous measurement of serum tryptophan and kynurenine by HPLC.

Authors:  B Widner; E R Werner; H Schennach; H Wachter; D Fuchs
Journal:  Clin Chem       Date:  1997-12       Impact factor: 8.327

4.  Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats.

Authors:  Afifa Ait-Belgnaoui; Henri Durand; Christel Cartier; Gilles Chaumaz; Hélène Eutamene; Laurent Ferrier; Eric Houdeau; Jean Fioramonti; Lionel Bueno; Vassilia Theodorou
Journal:  Psychoneuroendocrinology       Date:  2012-04-26       Impact factor: 4.905

Review 5.  The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.

Authors:  Jan M Ehrchen; Cord Sunderkötter; Dirk Foell; Thomas Vogl; Johannes Roth
Journal:  J Leukoc Biol       Date:  2009-05-18       Impact factor: 4.962

Review 6.  Calprotectin - a pleiotropic molecule in acute and chronic inflammation.

Authors:  I Stríz; I Trebichavský
Journal:  Physiol Res       Date:  2004       Impact factor: 1.881

7.  Peripheral administration of an anti-TNF-α receptor fusion protein counteracts the amyloid induced elevation of hippocampal TNF-α levels and memory deficits in mice.

Authors:  E R Detrait; B Danis; Y Lamberty; P Foerch
Journal:  Neurochem Int       Date:  2014-04-13       Impact factor: 3.921

8.  Simultaneous measurement of phenylalanine and tyrosine by high performance liquid chromatography (HPLC) with fluorescence detection.

Authors:  Gabriele Neurauter; Sabine Scholl-Bürgi; Astrid Haara; Simon Geisler; Peter Mayersbach; Harald Schennach; Dietmar Fuchs
Journal:  Clin Biochem       Date:  2013-10-29       Impact factor: 3.281

9.  Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study.

Authors:  Michael Manz; Emanuel Burri; Claude Rothen; Nuschin Tchanguizi; Christian Niederberger; Livio Rossi; Christoph Beglinger; Frank Serge Lehmann
Journal:  BMC Gastroenterol       Date:  2012-01-10       Impact factor: 3.067

10.  S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice model.

Authors:  Hee Jin Kim; Keun-A Chang; Tae-Young Ha; Jeonga Kim; Sungji Ha; Ki-Young Shin; Cheil Moon; Wolfgang Nacken; Hye-Sun Kim; Yoo-Hun Suh
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

View more
  23 in total

1.  Intestinal Alkaline Phosphatase Regulates Tight Junction Protein Levels.

Authors:  Wei Liu; Dong Hu; Haizhong Huo; Weifeng Zhang; Fatemeh Adiliaghdam; Sarah Morrison; Juan M Ramirez; Sarah S Gul; Sulaiman R Hamarneh; Richard A Hodin
Journal:  J Am Coll Surg       Date:  2015-12-18       Impact factor: 6.113

2.  Probiotics ameliorates LPS induced neuroinflammation injury on Aβ 1-42, APP, γ-β secretase and BDNF levels in maternal gut microbiota and fetal neurodevelopment processes.

Authors:  Fatih Kar; Ceyhan Hacioglu; Ezgi Kar; Dilek Burukoglu Donmez; Güngör Kanbak
Journal:  Metab Brain Dis       Date:  2022-03-21       Impact factor: 3.655

3.  Intestinal alkaline phosphatase targets the gut barrier to prevent aging.

Authors:  Florian Kühn; Fatemeh Adiliaghdam; Paul M Cavallaro; Sulaiman R Hamarneh; Amy Tsurumi; Raza S Hoda; Alexander R Munoz; Yashoda Dhole; Juan M Ramirez; Enyu Liu; Robin Vasan; Yang Liu; Ehsan Samarbafzadeh; Rocio A Nunez; Matthew Z Farber; Vanita Chopra; Madhu S Malo; Laurence G Rahme; Richard A Hodin
Journal:  JCI Insight       Date:  2020-03-26

4.  Gut microbial involvement in Alzheimer's disease pathogenesis.

Authors:  Yu Zhang; Rulin Geng; Qiuyun Tu
Journal:  Aging (Albany NY)       Date:  2021-05-10       Impact factor: 5.682

5.  Probiotic Supplements Beneficially Affect Tryptophan-Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial.

Authors:  Barbara Strasser; Daniela Geiger; Markus Schauer; Johanna M Gostner; Hannes Gatterer; Martin Burtscher; Dietmar Fuchs
Journal:  Nutrients       Date:  2016-11-23       Impact factor: 5.717

Review 6.  Personalizing the Care and Treatment of Alzheimer's Disease: An Overview.

Authors:  Dubravka Svob Strac; Marcela Konjevod; Marina Sagud; Matea Nikolac Perkovic; Gordana Nedic Erjavec; Barbara Vuic; Goran Simic; Vana Vukic; Ninoslav Mimica; Nela Pivac
Journal:  Pharmgenomics Pers Med       Date:  2021-05-28

7.  Commentary: Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial.

Authors:  Friedrich Leblhuber; Michael Egger; Burkhard Schuetz; Dietmar Fuchs
Journal:  Front Aging Neurosci       Date:  2018-03-06       Impact factor: 5.750

Review 8.  Harnessing the Power of Microbiome Assessment Tools as Part of Neuroprotective Nutrition and Lifestyle Medicine Interventions.

Authors:  Miguel Toribio-Mateas
Journal:  Microorganisms       Date:  2018-04-25

9.  Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study.

Authors:  Vanessa Stadlbauer; Lara Engertsberger; Irina Komarova; Nicole Feldbacher; Bettina Leber; Gerald Pichler; Nicole Fink; Monika Scarpatetti; Walter Schippinger; Reinhold Schmidt; Angela Horvath
Journal:  BMC Geriatr       Date:  2020-07-20       Impact factor: 3.921

10.  Probiotic Supplementation in Patients with Alzheimer's Dementia - An Explorative Intervention Study.

Authors:  Friedrich Leblhuber; Kostja Steiner; Burkhard Schuetz; Dietmar Fuchs; Johanna M Gostner
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.